Monogram Technologies Inc., an AI-driven robotics company specializing in orthopedic surgery, announced the mandatory conversion of its 8.00% Series D Convertible Cumulative Preferred Stock. This decision comes after the company's common stock maintained a closing price of at least $2.8125 per share for ten consecutive trading days, triggering the conversion as per the terms outlined in the Certificate of Designation. The conversion will take effect on July 14, 2025, impacting all outstanding shares issued during the company's October 1, 2024 offering. This strategic move is part of Monogram's ongoing efforts to streamline its capital structure and enhance shareholder value.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。